Report Detail
Global Urate-stimulating Excretion Agents Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4753314 |
- 05 October, 2026 |
- Global |
- 100 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Urate-stimulating Excretion Agents market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Urate-stimulating excretion agents are a class of medications designed to lower blood uric acid levels by enhancing its elimination from the body.They work by inhibiting the reabsorption of uric acid in the kidneys,which increases its excretion in the urine.These agents are used primarily in the treatment of chronic gout and hyperuricemia.
This report is a detailed and comprehensive analysis for global Urate-stimulating Excretion Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Urate-stimulating Excretion Agents market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Urate-stimulating Excretion Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Urate-stimulating Excretion Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Urate-stimulating Excretion Agents market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Urate-stimulating Excretion Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Urate-stimulating Excretion Agents market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fuji Yakuhin, Lannett Company, Teva, Eisai, AstraZeneca, Towa Pharmaceutical, Excella, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Urate-stimulating Excretion Agents market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Benzbromarone
Lesinurad
Dotinurad
Probenecid
Other
Market segment by Application
Hospitals and Clinics
Retail Pharmacies
Other
Major players covered
Fuji Yakuhin
Lannett Company
Teva
Eisai
AstraZeneca
Towa Pharmaceutical
Excella
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Urate-stimulating Excretion Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Urate-stimulating Excretion Agents, with price, sales quantity, revenue, and global market share of Urate-stimulating Excretion Agents from 2021 to 2026.
Chapter 3, the Urate-stimulating Excretion Agents competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Urate-stimulating Excretion Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Urate-stimulating Excretion Agents market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Urate-stimulating Excretion Agents.
Chapter 14 and 15, to describe Urate-stimulating Excretion Agents sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Urate-stimulating Excretion Agents Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Benzbromarone
- 1.3.3 Lesinurad
- 1.3.4 Dotinurad
- 1.3.5 Probenecid
- 1.3.6 Other
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Urate-stimulating Excretion Agents Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospitals and Clinics
- 1.4.3 Retail Pharmacies
- 1.4.4 Other
- 1.5 Global Urate-stimulating Excretion Agents Market Size & Forecast
- 1.5.1 Global Urate-stimulating Excretion Agents Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Urate-stimulating Excretion Agents Sales Quantity (2021-2032)
- 1.5.3 Global Urate-stimulating Excretion Agents Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Fuji Yakuhin
- 2.1.1 Fuji Yakuhin Details
- 2.1.2 Fuji Yakuhin Major Business
- 2.1.3 Fuji Yakuhin Urate-stimulating Excretion Agents Product and Services
- 2.1.4 Fuji Yakuhin Urate-stimulating Excretion Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Fuji Yakuhin Recent Developments/Updates
- 2.2 Lannett Company
- 2.2.1 Lannett Company Details
- 2.2.2 Lannett Company Major Business
- 2.2.3 Lannett Company Urate-stimulating Excretion Agents Product and Services
- 2.2.4 Lannett Company Urate-stimulating Excretion Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Lannett Company Recent Developments/Updates
- 2.3 Teva
- 2.3.1 Teva Details
- 2.3.2 Teva Major Business
- 2.3.3 Teva Urate-stimulating Excretion Agents Product and Services
- 2.3.4 Teva Urate-stimulating Excretion Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Teva Recent Developments/Updates
- 2.4 Eisai
- 2.4.1 Eisai Details
- 2.4.2 Eisai Major Business
- 2.4.3 Eisai Urate-stimulating Excretion Agents Product and Services
- 2.4.4 Eisai Urate-stimulating Excretion Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Eisai Recent Developments/Updates
- 2.5 AstraZeneca
- 2.5.1 AstraZeneca Details
- 2.5.2 AstraZeneca Major Business
- 2.5.3 AstraZeneca Urate-stimulating Excretion Agents Product and Services
- 2.5.4 AstraZeneca Urate-stimulating Excretion Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 AstraZeneca Recent Developments/Updates
- 2.6 Towa Pharmaceutical
- 2.6.1 Towa Pharmaceutical Details
- 2.6.2 Towa Pharmaceutical Major Business
- 2.6.3 Towa Pharmaceutical Urate-stimulating Excretion Agents Product and Services
- 2.6.4 Towa Pharmaceutical Urate-stimulating Excretion Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Towa Pharmaceutical Recent Developments/Updates
- 2.7 Excella
- 2.7.1 Excella Details
- 2.7.2 Excella Major Business
- 2.7.3 Excella Urate-stimulating Excretion Agents Product and Services
- 2.7.4 Excella Urate-stimulating Excretion Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Excella Recent Developments/Updates
3 Competitive Environment: Urate-stimulating Excretion Agents by Manufacturer
- 3.1 Global Urate-stimulating Excretion Agents Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Urate-stimulating Excretion Agents Revenue by Manufacturer (2021-2026)
- 3.3 Global Urate-stimulating Excretion Agents Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Urate-stimulating Excretion Agents by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Urate-stimulating Excretion Agents Manufacturer Market Share in 2025
- 3.4.3 Top 6 Urate-stimulating Excretion Agents Manufacturer Market Share in 2025
- 3.5 Urate-stimulating Excretion Agents Market: Overall Company Footprint Analysis
- 3.5.1 Urate-stimulating Excretion Agents Market: Region Footprint
- 3.5.2 Urate-stimulating Excretion Agents Market: Company Product Type Footprint
- 3.5.3 Urate-stimulating Excretion Agents Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Urate-stimulating Excretion Agents Market Size by Region
- 4.1.1 Global Urate-stimulating Excretion Agents Sales Quantity by Region (2021-2032)
- 4.1.2 Global Urate-stimulating Excretion Agents Consumption Value by Region (2021-2032)
- 4.1.3 Global Urate-stimulating Excretion Agents Average Price by Region (2021-2032)
- 4.2 North America Urate-stimulating Excretion Agents Consumption Value (2021-2032)
- 4.3 Europe Urate-stimulating Excretion Agents Consumption Value (2021-2032)
- 4.4 Asia-Pacific Urate-stimulating Excretion Agents Consumption Value (2021-2032)
- 4.5 South America Urate-stimulating Excretion Agents Consumption Value (2021-2032)
- 4.6 Middle East & Africa Urate-stimulating Excretion Agents Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Urate-stimulating Excretion Agents Sales Quantity by Type (2021-2032)
- 5.2 Global Urate-stimulating Excretion Agents Consumption Value by Type (2021-2032)
- 5.3 Global Urate-stimulating Excretion Agents Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Urate-stimulating Excretion Agents Sales Quantity by Application (2021-2032)
- 6.2 Global Urate-stimulating Excretion Agents Consumption Value by Application (2021-2032)
- 6.3 Global Urate-stimulating Excretion Agents Average Price by Application (2021-2032)
7 North America
- 7.1 North America Urate-stimulating Excretion Agents Sales Quantity by Type (2021-2032)
- 7.2 North America Urate-stimulating Excretion Agents Sales Quantity by Application (2021-2032)
- 7.3 North America Urate-stimulating Excretion Agents Market Size by Country
- 7.3.1 North America Urate-stimulating Excretion Agents Sales Quantity by Country (2021-2032)
- 7.3.2 North America Urate-stimulating Excretion Agents Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Urate-stimulating Excretion Agents Sales Quantity by Type (2021-2032)
- 8.2 Europe Urate-stimulating Excretion Agents Sales Quantity by Application (2021-2032)
- 8.3 Europe Urate-stimulating Excretion Agents Market Size by Country
- 8.3.1 Europe Urate-stimulating Excretion Agents Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Urate-stimulating Excretion Agents Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Urate-stimulating Excretion Agents Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Urate-stimulating Excretion Agents Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Urate-stimulating Excretion Agents Market Size by Region
- 9.3.1 Asia-Pacific Urate-stimulating Excretion Agents Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Urate-stimulating Excretion Agents Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Urate-stimulating Excretion Agents Sales Quantity by Type (2021-2032)
- 10.2 South America Urate-stimulating Excretion Agents Sales Quantity by Application (2021-2032)
- 10.3 South America Urate-stimulating Excretion Agents Market Size by Country
- 10.3.1 South America Urate-stimulating Excretion Agents Sales Quantity by Country (2021-2032)
- 10.3.2 South America Urate-stimulating Excretion Agents Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Urate-stimulating Excretion Agents Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Urate-stimulating Excretion Agents Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Urate-stimulating Excretion Agents Market Size by Country
- 11.3.1 Middle East & Africa Urate-stimulating Excretion Agents Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Urate-stimulating Excretion Agents Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Urate-stimulating Excretion Agents Market Drivers
- 12.2 Urate-stimulating Excretion Agents Market Restraints
- 12.3 Urate-stimulating Excretion Agents Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Urate-stimulating Excretion Agents and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Urate-stimulating Excretion Agents
- 13.3 Urate-stimulating Excretion Agents Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Urate-stimulating Excretion Agents Typical Distributors
- 14.3 Urate-stimulating Excretion Agents Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Urate-stimulating Excretion Agents. Industry analysis & Market Report on Urate-stimulating Excretion Agents is a syndicated market report, published as Global Urate-stimulating Excretion Agents Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Urate-stimulating Excretion Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
